Ceeto Capital Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.7M	Buy	3,240 +1,200	+59%	+$630K	0.59%	38
2025 Q1	$1.29M	Hold	2,040	–	–	0.49%	46
2024 Q4	$1.45M	Hold	2,040	–	–	0.53%	40
2024 Q3	$2.15M	Buy	2,040 +500	+32%	+$526K	0.8%	26
2024 Q2	$1.62M	Buy	1,540 +500	+48%	+$526K	0.63%	38
2024 Q1	$1M	Hold	1,040	–	–	0.41%	59
2023 Q4	$913K	Hold	1,040	–	–	0.39%	59
2023 Q3	$856K	Hold	1,040	–	–	0.41%	53
2023 Q2	$747K	Sell	1,040 -7	-0.7%	-$5.03K	0.34%	64
2023 Q1	$860K	Buy	1,047 +7	+0.7%	+$5.75K	0.43%	56
2022 Q4	$750K	Hold	1,040	–	–	0.41%	58
2022 Q3	$716K	Sell	1,040 -1,000	-49%	-$688K	0.41%	61
2022 Q2	$1.21M	Sell	2,040 -500	-20%	-$296K	0.66%	44
2022 Q1	$1.77M	Hold	2,540	–	–	0.81%	33
2021 Q4	$1.6M	Sell	2,540 -560	-18%	-$354K	0.67%	39
2021 Q3	$1.88M	Sell	3,100 -500	-14%	-$303K	0.88%	27
2021 Q2	$2.01M	Hold	3,600	–	–	0.91%	31
2021 Q1	$1.7M	Hold	3,600	–	–	0.83%	35
2020 Q4	$1.74M	Hold	3,600	–	–	0.88%	31
2020 Q3	$2.02M	Hold	3,600	–	–	1.13%	17
2020 Q2	$2.25M	Hold	3,600	–	–	1.45%	10
2020 Q1	$1.76M	Hold	3,600	–	–	1.41%	13
2019 Q4	$1.35M	Hold	3,600	–	–	0.88%	32
2019 Q3	$999K	Sell	3,600 -150	-4%	-$41.6K	0.72%	42
2019 Q2	$1.17M	Buy	3,750 +100	+3%	+$31.3K	0.86%	37
2019 Q1	$1.5M	Hold	3,650	–	–	1.1%	23
2018 Q4	$1.36M	Hold	3,650	–	–	1.13%	25
2018 Q3	$1.48M	Buy	3,650 +150	+4%	+$60.6K	1.01%	27
2018 Q2	$1.21M	Buy	3,500 +1,000	+40%	+$345K	0.9%	31
2018 Q1	$861K	Hold	2,500	–	–	0.65%	51
2017 Q4	$940K	Buy	2,500 +1,000	+67%	+$376K	0.67%	47
2017 Q3	$671K	Buy	+1,500	New	+$671K	0.5%	73